BOSTON, MA / ACCESSWIRE / March 27, 2020 / Thornton Law Firm LLP alerts investors that a class action lawsuit has been filed against AnaptysBio, Inc. on behalf of ANAB shareholders (NASDAQ:ANAB). Investors who have purchased at least 1,000 shares of ANAB stock between October 10, 2017 and November 7, 2019 are encouraged to submit their information at https://www.tenlaw.com/cases/ANAB to learn more about the lead plaintiff process. Shareholders may also contact the Thornton Law Firm at shareholder@tenlaw.com, or call 617-531-3917. There is no minimum number of shares required to be a class member.
FOR MORE INFORMATION, VISIT: https://www.tenlaw.com/cases/ANAB
The lawsuit alleges that AnaptysBio made misleading statements regarding the efficacy of etokimab, a drug for inflammatory diseases. The case alleges that AnaptysBio hyped data from their Phase 2a trial in peanut allergies as showing a "remarkable efficacy result" and described the drug as having a "pretty profound efficacy" in its treatment of patients with atopic dermatitis based on AnaptysBio's Phase 2a trial data for that indication. The lawsuit alleges that AnaptysBio provided misleading clinical trial data which failed to disclose key information and used questionable analysis, making the trial results regarding etokimab's efficacy and its prospects appear far better than they were. It is alleged that shareholders lost significant value as a result of these misstatements when the truth was disclosed beginning in November 2019.
Investors who purchased at least 1,000 shares of ANAB stock (NASDAQ: ANAB) are encouraged to contact the Thornton Law Firm's shareholder rights team at www.tenlaw.com/cases/ANAB, by email at shareholder@tenlaw.com, or calling 617-531-3917 to discuss the lead plaintiff process.
Interested ANAB shareholders have until May 26, 2020 to apply to be lead plaintiff. The lawsuit alleges violations of the federal securities laws, and the class has not yet been certified. Until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member. There is no minimum amount of shares required to be able to participate as a class member.
FOR MORE INFORMATION: https://www.tenlaw.com/cases/ANAB
Thornton Law Firm's securities attorneys are highly experienced in representing individual shareholders and institutional investors in recovering damages caused by violations of the securities laws. Its attorneys have established track records litigating securities cases in courts throughout the country and recovering losses on behalf of shareholders. This may be considered Attorney Advertising in some jurisdictions. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
CONTACT:
Thornton Law Firm LLP
State Street Financial Center
1 Lincoln Street
Boston, MA 02111
SOURCE: Thornton Law Firm LLP
View source version on accesswire.com:
https://www.accesswire.com/582900/AnaptysBio-Investor-Alert-Class-Action-Lawsuit-Filed
